What's being said on the web about "qnexa"

  • Qnexa is an anti-obesity drug manufactured by Vivus, Inc. A 28 week study was done on 45 obese sleep apnea patients in 69% of the participants sleep apnea was reduced due to weight loss and a greater concentration of oxygen. ... [view original]

  • (Nasdaq: VVUS) today announced that the US Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa, for the treatment of obesity. ... [view original]

  • VIVUS Announces the Issuances of Three Additional Qnexa(R) Patents New Patents Broaden Protection for Qnexa PR Newswire MOUNTAIN VIEW, Calif., March. [view original]

  • Clinical trials have shown that the Qnexa diet pill is effective and safe. This weight loss drug is taken by mouth, once a day. It's got a tiny dose formulation, so its manufacturer claims that it is well endured by its users. ... [view original]

  • A small-scale, mid-stage trial of Qnexa, which is an experimental weight-loss medicine developed by Vivus Inc., has revealed that the drug can actually manage to reduce the incidence of sleep apnea events by about 69%, as confirmed by ... [view original]

  • Experts claim that patients can lose as much weight with Qnexa as they would if they had obesity surgery. Dr Kishore Gadde, director of obesity clinical trials at Duke University in North Carolina, who led the study, said: “The weight ... [view original]

  • One of these products is Qnexa. According to its manufacturer, Vivus Inc., Qnexa is a diet pill which is composed of phentermine and topiramate. Phentermine is the most frequently used chemical for the treatment of obesity. ... [view original]

  • One of these products is Qnexa. According to its manufacturer, Vivus Inc., Qnexa is a diet pill which is composed of phentermine and topiramate. Phentermine is the most commonly used chemical for the handling of obesity. ... [view original]

  • One of these products is Qnexa. According to its manufacturer, Vivus Inc., Qnexa is a diet pill which is composed of phentermine and topiramate. Phentermine is the most typically used chemical for the handling of obesity. ... [view original]

  • (Nasdaq: VVUS) today announced the issuance of three additional patents by the US Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents. [view original]

  • Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of obesity, Vivus's Qnexa (the phentermine/topiramate combination) will earn Decision ... [view original]

  • VIVUS announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa, our investigational drug candidate, for the treatment of obstructive sleep apnea (OSA). This study demonstrated statistically significant ... [view original]

  • Clinical tests have shown that the Qnexa diet pill is effective and safe. This weight loss drug is taken orally, once a day. It has got a tiny dose formulation, so its manufacturer claims that it is well tolerated by its users. ... [view original]

  • One of these products is Qnexa. According to its manufacturer, Vivus Inc., Qnexa is a diet pill which is composed of phentermine and topiramate. Phentermine is the most commonly used chemical for the treating of obesity. ... [view original]

  • Youre searching for {0}? At oneview youll find recommended web sites and tips. [view original]

  • One of these products is Qnexa. According to its manufacturer, Vivus Inc., Qnexa is a diet pill which is made of phentermine and topiramate. Phentermine is the most typically used chemical for the handling of obesity. ... [view original]

  • tags: Qnexa Forum, Qnexa, Qnexa Before and After Pictures, Qnexa Side Effects,. no comments. [view original]

  • VIVUS, Inc. today announced that the US Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA ... [view original]

  • 07:03 AM Eastern Standard Time, 03/08/2010 (MidnightTrader) — VIVUS (VVUS) announced the issuance of three additional patents by the US Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the ... [view original]

  • Vivus, Inc, a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, [view original]

share

Video results for: qnexa

youtube Youtube_fav
    truveo Truveo_fav